Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Adrenal Insufficiency”

47 trials

Showing 20 of 47 results

Post-approval studies (Phase 4)Study completedNCT02277587
What this trial is testing

Dual RElease Hydrocortisone Versus conventionAl Glucocorticoid replaceMent Therapy in Hypocortisolism (DREAM)

Who this might be right for
Primary Adrenal InsufficiencySecondary Adrenal Insufficiency
University of Roma La Sapienza 89
Testing effectiveness (Phase 2)Study completedNCT02933528
What this trial is testing

Safety Study to Assess the Potential for Adrenal Suppression Following Maximal Use Treatment With DSXS

Who this might be right for
Psoriasis
Sun Pharmaceutical Industries, Inc. 24
Post-approval studies (Phase 4)Ended earlyNCT03212963
What this trial is testing

Evaluation of Adrenal Suppression Potential and Pharmacokinetics of Halobetasol Lotion 0.05%

Who this might be right for
Plaque Psoriasis
Sun Pharmaceutical Industries Limited 16
Not applicableStudy completedNCT04416217
What this trial is testing

Eosinophilic Esophagitis Steroid Safety Study

Who this might be right for
Eosinophilic Esophagitis
Rabin Medical Center 55
Testing effectiveness (Phase 2)Study completedNCT02131324
What this trial is testing

DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Promius Pharma, LLC 50
Testing effectiveness (Phase 2)Study completedNCT02933502
What this trial is testing

Safety Study in Patients With Scalp Psoriasis Suppression Following Maximal Use Treatment With Topical Product

Who this might be right for
Scalp Psoriasis
Sun Pharmaceutical Industries, Inc. 3
Post-approval studies (Phase 4)UnknownNCT02282150
What this trial is testing

Modified-release Compared to Conventional Hydrocortisone on Diurnal Fatigue in Secondary Hypoadrenalism

Who this might be right for
Adrenal Insufficiency
Ulla Feldt-Rasmussen 30
Large-scale testing (Phase 3)Ended earlyNCT02527421
What this trial is testing

DFD01 Spray HPA Axis Suppression Study in Adolescent Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Primus Pharmaceuticals 3
Testing effectiveness (Phase 2)Study completedNCT01698333
What this trial is testing

Pharmacokinetics of 122-0551 and Its Effects on Adrenal Suppression

Who this might be right for
Plaque Psoriasis
Therapeutics, Inc. 25
Post-approval studies (Phase 4)Study completedNCT03992261
What this trial is testing

Adrenal Suppression and Absorption Study of Halobetasol Propionate Foam in Subjects 12-17 With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Mayne Pharma International Pty Ltd 24
Testing effectiveness (Phase 2)Ended earlyNCT03179605
What this trial is testing

Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD-06

Who this might be right for
Psoriasis
Primus Pharmaceuticals 22
Post-approval studies (Phase 4)Study completedNCT01546922
What this trial is testing

Hydrocortisone Replacement in Patients With Secondary Adrenal Insufficiency (SUPREME CORT)

Who this might be right for
Adrenal Insufficiency
University Medical Center Groningen 63
Not applicableStudy completedNCT04322435
What this trial is testing

Prevalence of Hypoglycaemia in Congenital Adrenal Insufficiency

Who this might be right for
Adrenal Insufficiency, Congenital
Assistance Publique - Hôpitaux de Paris 9
Testing effectiveness (Phase 2)Study completedNCT01043393
What this trial is testing

Desoximetasone Spray 0.25%, Hypothalamic Pituitary Adrenal (HPA) Axis Study

Who this might be right for
Psoriasis
Sun Pharmaceutical Industries, Inc. 24
Early research (Phase 1)Study completedNCT03645499
What this trial is testing

An Open-Label Study to Assess Safety

Who this might be right for
Plaque Psoriasis
Sun Pharmaceutical Industries, Inc. 88
Testing effectiveness (Phase 2)Study completedNCT01831960
What this trial is testing

An Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of CB-03-01 Cream in Subjects With Acne Vulgaris

Who this might be right for
Acne Vulgaris
Intrepid Therapeutics, Inc. 42
Very early researchWithdrawnNCT01422733
What this trial is testing

Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen Overproduction

Who this might be right for
HyperandrogenemiaObesityPolycystic Ovary Syndrome
University of Virginia
Testing effectiveness (Phase 2)Study completedNCT02932878
What this trial is testing

An Open Label, Safety Study to Assess the Potential for Adrenal Suppression

Who this might be right for
Plaque Psoriasis
Sun Pharmaceutical Industries, Inc. 16
Testing effectiveness (Phase 2)Study completedNCT02595008
What this trial is testing

Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Sun Pharmaceutical Industries, Inc. 24
Testing effectiveness (Phase 2)Study completedNCT02932891
What this trial is testing

An Open Label, Safety Study to Assess the Potential for Adrenal Suppression.

Who this might be right for
Atopic Dermatitis
Sun Pharmaceutical Industries, Inc. 28
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation